Infection strategies of enteric pathogenic Escherichia coli

Gut Microbes

Volumn 3, Issue 2, 2012, Pages 71-87

  Clements, Abigail ^a   Young, Joanna C ^a   Constantinou, Nicholas ^a   Frankel, Gad ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Enteric E. coli; Gut microbes; Host pathogen interactions; Molecular mechanisms of pathogenesis; T3SS

Indexed keywords

ADHESIN; CYTOLYSIN; ESCHERICHIA COLI ENTEROTOXIN; HEMOLYSIN; INTIMIN; OUTER MEMBRANE PROTEIN A; SERINE PROTEINASE; SHIGA TOXIN; VIRULENCE FACTOR;

ACUTE DIARRHEA; ADHERENT INVASIVE ESCHERICHIA COLI; APOPTOSIS; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CELL SURVIVAL; CROHN DISEASE; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROINVASIVE ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; ENTEROTOXIGENIC ESCHERICHIA COLI; FOOD POISONING; HUMAN; IMMUNE RESPONSE; INFANTILE DIARRHEA; INFECTIOUS DIARRHEA; INTESTINE FLORA; NONHUMAN; PHAGOCYTOSIS; REVIEW; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SHIGELLOSIS; TRAVELLER DIARRHEA; TYPE III SECRETION SYSTEM; DIARRHEA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GENETICS; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; VIRULENCE;

ESCHERICHIA COLI;

DIARRHEA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; VIRULENCE; VIRULENCE FACTORS;

EID: 84866462420     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.19182     Document Type: Review

References (194)

1. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11:142-201. PMID: 9457432
2. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2:123-140. PMID:15040260; http://dx.doi.org/10.1038/nrmicro818
3. Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 2010; 8:26-38. PMID:19966814
4. Wolf MK. Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin Microbiol Rev 1997; 10:569-584. PMID:9336662
5. Berger CN, Sodha SV, Shaw RK, Griffin PM, Pink D, Hand P, et al. Fresh fruit and vegetables as vehicles for the transmission of human pathogens. Environ Microbiol 2010; 12:2385-2397. PMID:20636374; http://dx.doi.org/10.1111/j.1462-2920.2010.02297.x
6. Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 2005; 18:465-483. PMID:16020685; http://dx.doi.org/10.1128/CMR.18.3.465-483.2005
7. Gascón J, Vargas M, Quintó L, Corachán M, Jimenez de Anta MT, Vila J. Enteroaggregative Escherichia coli strains as a cause of traveler's diarrhea: a case-control study. J Infect Dis 1998; 177:1409-1412. PMID: 9593036; http://dx.doi.org/10.1086/517826
8. Black RE. Epidemiology of travelers' diarrhea and relative importance of various pathogens. Rev Infect Dis 1990; 12(Suppl 1):S73-S79. PMID:2406860; http://dx.doi.org/10.1093/clinids/12.Supplement_1.S73
9. Steffen R, Castelli F, Dieter Nothdurft H, Rombo L, Jane Zuckerman N. Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea. J Travel Med 2005; 12:102-107. PMID:15996455; http://dx.doi.org/10.2310/7060.2005.12207
10. Nagy B, Fekete PZ. Enterotoxigenic Escherichia coli in veterinary medicine. Int J Med Microbiol 2005; 295:443-454. PMID:16238018; http://dx.doi.org/10.1016/j.ijmm.2005.07.003
11. Shah N, DuPont HL, Ramsey DJ. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med Hyg 2009; 80:609-614. PMID:19346386
12. Sarantuya J, Nishi J, Wakimoto N, Erdene S, Nataro JP, Sheikh J, et al. Typical enteroaggregative Escherichia coli is the most prevalent pathotype among E. coli strains causing diarrhea in Mongolian children. J Clin Microbiol 2004; 42:133-139. PMID:14715743; http://dx.doi.org/10.1128/JCM.42.1.133-139.2004
13. Dutta S, Pal S, Chakrabarti S, Dutta P, Manna B. Use of PCR to identify enteroaggregative Escherichia coli as an important cause of acute diarrhoea among children living in Calcutta, India. J Med Microbiol 1999; 48:1011-1016. PMID:10535645; http://dx.doi.org/10.1099/00222615-48-11-1011
14. Wanke CA, Mayer H, Weber R, Zbinden R, Watson DA, Acheson D. Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus. J Infect Dis 1998; 178:185-190. PMID:9652439; http://dx.doi.org/10.1086/314443
15. Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 2011; 11: 671-676. PMID:21703928
16. RKI. EHEC/HUS O104:H4 - The outbreak is considered to be over. Robert Koch Institute, 2011.
17. Mellmann A, Bielaszewska M, Köck R, Friedrich AW, Fruth A, Middendorf B, et al. Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg Infect Dis 2008; 14:1287-1290. PMID:18680658; http://dx.doi.org/10.3201/eid1408.071082
18. Bae WK, Lee YK, Cho MS, Ma SK, Kim SW, Kim NH, et al. A case of hemolytic uremic syndrome caused by Escherichia coli O104:H4. Yonsei Med J 2006; 47:437-439. PMID:16807997; http://dx.doi.org/10.3349/ymj.2006.47.3.437
19. Snelling AM, Macfarlane-Smith LR, Fletcher JN, Okeke IN. The commonly-used DNA probe for diffusely-adherent Escherichia coli cross-reacts with a subset of enteroaggregative E. coli. BMC Microbiol 2009; 9:269. PMID:20025771; http://dx.doi.org/10.1186/1471-2180-9-269
20. Gunzburg ST, Chang BJ, Elliott SJ, Burke V, Gracey M. Diffuse and enteroaggregative patterns of adherence of enteric Escherichia coli isolated from aboriginal children from the Kimberley region of Western Australia. J Infect Dis 1993; 167:755-758. PMID: 8440943; http://dx.doi.org/10.1093/infdis/167.3.755
21. Scaletsky IC, Fabbricotti SH, Carvalho RL, Nunes CR, Maranhão HS, Morais MB, et al. Diffusely adherent Escherichia coli as a cause of acute diarrhea in young children in Northeast Brazil: a case-control study. J Clin Microbiol 2002; 40:645-648. PMID: 11825986; http://dx.doi.org/10.1128/JCM.40.2.645-648.2002
22. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127:412-421. PMID:15300573; http://dx.doi.org/10.1053/j.gastro.2004.04.061
23. Rolhion N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis 2007; 13:1277-1283. PMID: 17476674; http://dx.doi.org/10.1002/ibd.20176
24. Scallan E, Hoekstra RM, Widdowson MA, Hall AJ, Griffin PM. Foodborne illness acquired in the United States. Emerg Infect Dis 2011; 17:1339-1340; http://dx.doi.org/10.3201/eid1707.110572
25. Barton Behravesh C, Jones TF, Vugia DJ, Long C, Marcus R, Smith K, et al & FoodNet Working Group. Deaths associated with bacterial pathogens transmitted commonly through food: foodborne diseases active surveillance network (FoodNet), 1996-2005. J Infect Dis 2011; 204:263-267. PMID:21673037; http://dx.doi.org/10.1093/infdis/jir263
26. European Food Safety Authority. The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2009. EFSA Journal 2011; 9:2090-2468.
27. Neter E, Westphal O, Luderitz O, Gino RM, Gorzynski EA. Demonstration of antibodies against enteropathogenic Escherichia coli in sera of children of various ages. Pediatrics 1955; 16:801-808. PMID: 13273119
28. Bray J. Isolation of antigenically homogenous strains of Bact. coli neopolitanum from summer diarrhoea of infants. J Pathol Bacteriol 1945; 57:239-247; http://dx.doi.org/10.1002/path.1700570210
29. Ochoa TJ, Barletta F, Contreras C, Mercado E. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans R Soc Trop Med Hyg 2008; 102:852-856. PMID:18455741; http://dx.doi.org/10.1016/j.trstmh.2008.03.017
30. Nguyen RN, Taylor LS, Tauschek M, Robins-Browne RM. Atypical enteropathogenic Escherichia coli infection and prolonged diarrhea in children. Emerg Infect Dis 2006; 12:597-603. PMID:16704807
31. Afset JE, Bevanger L, Romundstad P, Bergh K. Association of atypical enteropathogenic Escherichia coli (EPEC) with prolonged diarrhoea. J Med Microbiol 2004; 53:1137-1144. PMID:15496393; http://dx.doi.org/10.1099/jmm.0.45719-0
32. Yang J, Nie H, Chen L, Zhang X, Yang F, Xu X, et al. Revisiting the molecular evolutionary history of Shigella spp. J Mol Evol 2007; 64:71-79. PMID: 17160643; http://dx.doi.org/10.1007/s00239-006-0052-8
33. Gaastra W, Svennerholm AM. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol 1996; 4:444-452. PMID:8950814; http://dx.doi.org/10.1016/0966-842X(96)10068-8
34. Nada RA, Shaheen HI, Khalil SB, Mansour A, El-Sayed N, Touni I, et al. Discovery and phylogenetic analysis of novel members of class b enterotoxigenic Escherichia coli adhesive fimbriae. J Clin Microbiol 2011; 49:1403-1410. PMID:21289147; http://dx.doi.org/10.1128/JCM.02006-10
35. Elsinghorst EA, Kopecko DJ. Molecular cloning of epithelial cell invasion determinants from enterotoxigenic Escherichia coli. Infect Immun 1992; 60:2409-2417. PMID:1587608
36. Shaw RK, Berger CN, Pallen MJ, Sjöling Å, Frankel G. Flagella mediate attachment of enterotoxigenic Escherichia coli to fresh salad leaves. Env Microbiol Rep 2011; 3:112-117; http://dx.doi.org/10.1111/j.1758-2229.2010.00195.x
37. Roy K, Hilliard GM, Hamilton DJ, Luo J, Ostmann MM, Fleckenstein JM. Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells. Nature 2009; 457:594-598. PMID:19060885; http://dx.doi.org/10.1038/nature07568
38. Roy K, Kansal R, Bartels SR, Hamilton DJ, Shaaban S, Fleckenstein JM. Adhesin degradation accelerates delivery of heat-labile toxin by enterotoxigenic Escherichia coli. J Biol Chem 2011; 286:29771-29779. PMID:21757737; http://dx.doi.org/10.1074/jbc.M111.251546
39. Schulz S, Green CK, Yuen PS, Garbers DL. Guanylyl cyclase is a heat-stable enterotoxin receptor. Cell 1990; 63:941-948. PMID:1701694; http://dx.doi.org/10.1016/0092-8674(90)90497-3
40. Vaandrager AB. Structure and function of the heatstable enterotoxin receptor/guanylyl cyclase C. Mol Cell Biochem 2002; 230:73-83. PMID:11952098; http://dx.doi.org/10.1023/A:1014231722696
41. Chao AC, de Sauvage FJ, Dong YJ, Wagner JA, Goeddel DV, Gardner P. Activation of intestinal CFTR Cl- channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase. EMBO J 1994; 13:1065-1072. PMID:7510634
42. Tauschek M, Gorrell RJ, Strugnell RA, Robins-Browne RM. Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc Natl Acad Sci U S A 2002; 99:7066-7071. PMID:12011463; http://dx.doi.org/10.1073/pnas.092152899
43. Horstman AL, Bauman SJ, Kuehn MJ. Lipopolysaccharide 3-deoxy-D-manno-octulosonic acid (Kdo) core determines bacterial association of secreted toxins. J Biol Chem 2004; 279:8070-8075. PMID:14660669; http://dx.doi.org/10.1074/jbc.M308633200
44. Kesty NC, Mason KM, Reedy M, Miller SE, Kuehn MJ. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J 2004; 23:4538-4549. PMID:15549136; http://dx.doi.org/10.1038/sj.emboj.7600471
45. Spangler BD. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev 1992; 56:622-647. PMID:1480112
46. Ludwig A, Bauer S, Benz R, Bergmann B, Goebel W. Analysis of the SlyA-controlled expression, subcellular localization and pore-forming activity of a 34 kDa haemolysin (ClyA) from Escherichia coli K-12. Mol Microbiol 1999; 31:557-567. PMID:10027972; http://dx.doi.org/10.1046/j.1365-2958.1999.01196.x
47. Berger CN, Shaw RK, Ruiz-Perez F, Nataro JP, Henderson IR, Pallen MJ, et al. Interaction of enteroaggregative Escherichia coli with salad leaves. Env Microbiol Rep 2009; 1:234-239; http://dx.doi.org/10.1111/j.1758-2229.2009.00037.x
48. Nataro JP, Deng Y, Maneval DR, German AL, Martin WC, Levine MM. Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes. Infect Immun 1992; 60:2297-2304. PMID:1350273
49. Czeczulin JR, Balepur S, Hicks S, Phillips A, Hall R, Kothary MH, et al. Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun 1997; 65:4135-4145. PMID:9317019
50. Harrington SM, Sheikh J, Henderson IR, Ruiz-Perez F, Cohen PS, Nataro JP. The Pic protease of enteroaggregative Escherichia coli promotes intestinal colonization and growth in the presence of mucin. Infect Immun 2009; 77:2465-2473. PMID:19349428; http://dx.doi.org/10.1128/IAI.01494-08
51. Mancini J, Weckselblatt B, Chung YK, Durante JC, Andelman S, Glaubman J, et al. The heat-resistant agglutinin family includes a novel adhesin from enteroaggregative Escherichia coli strain 60A. J Bacteriol 2011; 193:4813-4820. PMID:21764925; http://dx.doi.org/10.1128/JB.05142-11
52. Sheikh J, Czeczulin JR, Harrington S, Hicks S, Henderson IR, Le Bouguénec C, et al. A novel dispersin protein in enteroaggregative Escherichia coli. J Clin Invest 2002; 110:1329-1337. PMID:12417572
53. Henderson IR, Czeczulin J, Eslava C, Noriega F, Nataro JP. Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infect Immun 1999; 67:5587-5596. PMID: 10531204
54. Navarro-Garcia F, Gutierrez-Jimenez J, Garcia-Tovar C, Castro LA, Salazar-Gonzalez H, Cordova V. Pic, an autotransporter protein secreted by different pathogens in the Enterobacteriaceae family, is a potent mucus secretagogue. Infect Immun 2010; 78:4101-4109. PMID: 20696826; http://dx.doi.org/10.1128/IAI.00523-10
55. Ruiz-Perez F, Wahid R, Faherty CS, Kolappaswamy K, Rodriguez L, Santiago A, et al. Serine protease autotransporters from Shigella flexneri and pathogenic Escherichia coli target a broad range of leukocyte glycoproteins. Proc Natl Acad Sci U S A 2011; 108:12881-12886. PMID:21768350; http://dx.doi.org/10.1073/pnas.1101006108
56. Eslava C, Navarro-García F, Czeczulin JR, Henderson IR, Cravioto A, Nataro JP. Pet, an autotransporter enterotoxin from enteroaggregative Escherichia coli. Infect Immun 1998; 66:3155-3163. PMID:9632580
57. Cappello RE, Estrada-Gutierrez G, Irles C, Giono-Cerezo S, Bloch RJ, Nataro JP. Effects of the plasmidencoded toxin of enteroaggregative Escherichia coli on focal adhesion complexes. FEMS Immunol Med Microbiol 2011; 61:301-314. PMID:21205005; http://dx.doi.org/10.1111/j.1574-695X.2010.00776.x
58. Czeczulin JR, Whittam TS, Henderson IR, Navarro-Garcia F, Nataro JP. Phylogenetic analysis of enteroaggregative and diffusely adherent Escherichia coli. Infect Immun 1999; 67:2692-2699. PMID:10338471
59. Savarino SJ, Fasano A, Watson J, Martin BM, Levine MM, Guandalini S, et al. Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin. Proc Natl Acad Sci U S A 1993; 90:3093-3097. PMID: 8385356; http://dx.doi.org/10.1073/pnas.90.7.3093
60. Rich C, Favre-Bonte S, Sapena F, Joly B, Forestier C. Characterization of enteroaggregative Escherichia coli isolates. FEMS Microbiol Lett 1999; 173:55-61. PMID:10220881; http://dx.doi.org/10.1111/j.1574-6968.1999.tb13484.x
61. Zamboni A, Fabbricotti SH, Fagundes-Neto U, Scaletsky IC. Enteroaggregative Escherichia coli virulence factors are found to be associated with infantile diarrhea in Brazil. J Clin Microbiol 2004; 42:1058-1063. PMID:15004053; http://dx.doi.org/10.1128/JCM.42.3.1058-1063.2004
62. Fasano A, Noriega FR, Maneval DR, Jr., Chanasongcram S, Russell R, Guandalini S, et al. Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro. J Clin Invest 1995; 95:2853-2861. PMID: 7769126; http://dx.doi.org/10.1172/JCI117991
63. Mueller M, Grauschopf U, Maier T, Glockshuber R, Ban N. The structure of a cytolytic a-helical toxin pore reveals its assembly mechanism. Nature 2009; 459:726-730. PMID:19421192; http://dx.doi.org/10.1038/nature08026
64. Chaudhuri RR, Sebaihia M, Hobman JL, Webber MA, Leyton DL, Goldberg MD, et al. Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. PLoS One 2010; 5:e8801. PMID: 20098708; http://dx.doi.org/10.1371/journal.pone.0008801
65. Aslani MM, Alikhani MY, Zavari A, Yousefi R, Zamani AR. Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern. Int J Infect Dis 2011; 15: e136-e139. PMID:21130676; http://dx.doi.org/10.1016/j.ijid.2010.10.002
66. Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, et al. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One 2011; 6: e22751. PMID:21799941; http://dx.doi.org/10.1371/journal.pone.0022751
67. Tarr PI, Bilge SS, Vary JC, Jr., Jelacic S, Habeeb RL, Ward TR, et al. Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure. Infect Immun 2000; 68:1400-1407. PMID:10678953; http://dx.doi.org/10.1128/IAI.68.3.1400-1407.2000
68. Bielaszewska M, Middendorf B, Tarr PI, Zhang W, Prager R, Aldick T, et al. Chromosomal instability in enterohaemorrhagic Escherichia coli O157:H7: impact on adherence, tellurite resistance and colony phenotype. Mol Microbiol 2011; 79:1024-1044. PMID: 21299654; http://dx.doi.org/10.1111/j.1365-2958.2010.07499.x
69. Guignot J, Peiffer I, Bernet-Camard MF, Lublin DM, Carnoy C, Moseley SL, et al. Recruitment of CD55 and CD66e brush border-associated glycosylphosphatidylinositol-anchored proteins by members of the Afa/Dr diffusely adhering family of Escherichia coli that infect the human polarized intestinal Caco-2/TC7 cells. Infect Immun 2000; 68:3554-3563. PMID: 10816511; http://dx.doi.org/10.1128/IAI.68.6.3554-3563.2000
70. Berger CN, Billker O, Meyer TF, Servin AL, Kansau I. Differential recognition of members of the carcinoembryonic antigen family by Afa/Dr adhesins of diffusely adhering Escherichia coli (Afa/Dr DAEC). Mol Microbiol 2004; 52:963-983. PMID:15130118; http://dx.doi.org/10.1111/j.1365-2958.2004.04033.x
71. Nowicki B, Moulds J, Hull R, Hull S. A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen. Infect Immun 1988; 56:1057-1060. PMID:2895740
72. Ochoa TJ, Rivera FP, Bernal M, Meza R, Ecker L, Gil AI, et al. Detection of the CS20 colonization factor antigen in diffuse-adhering Escherichia coli strains. FEMS Immunol Med Microbiol 2010; 60:186-189. PMID:21064230; http://dx.doi.org/10.1111/j.1574-695X.2010.00730.x
73. Queval CJ, Nicolas V, Beau I. Role of Src kinases in mobilization of glycosylphosphatidylinositol-anchored decay-accelerating factor by Dr fimbria-positive adhering bacteria. Infect Immun 2011; 79:2519-2534. PMID: 21518786; http://dx.doi.org/10.1128/IAI.01052-10
74. Cane G, Ginouvès A, Marchetti S, Buscà R, Pouysségur J, Berra E, et al. HIF-1alpha mediates the induction of IL-8 and VEGF expression on infection with Afa/Dr diffusely adhering E. coli and promotes EMT-like behaviour. Cell Microbiol 2010; 12:640-653. PMID:20039880; http://dx.doi.org/10.1111/j.1462-5822.2009.01422.x
75. Bétis F, Brest P, Hofman V, Guignot J, Kansau I, Rossi B, et al. Afa/Dr diffusely adhering Escherichia coli infection in T84 cell monolayers induces increased neutrophil transepithelial migration, which in turn promotes cytokine-dependent upregulation of decayaccelerating factor (CD55), the receptor for Afa/Dr adhesins. Infect Immun 2003; 71:1774-1783. PMID: 12654791; http://dx.doi.org/10.1128/IAI.71.4.1774-1783.2003
76. Sémiramoth N, Gleizes A, Turbica I, Sandré C, Gorges R, Kansau I, et al. Escherichia coli type 1 pili trigger late IL-8 production by neutrophil-like differentiated PLB-985 cells through a Src family kinase- and MAPK-dependent mechanism. J Leukoc Biol 2009; 85:310-321. PMID:19015376; http://dx.doi.org/10.1189/jlb.0608350
77. Brest P, Bétis F, Cuburu N, Selva E, Herrant M, Servin A, et al. Increased rate of apoptosis and diminished phagocytic ability of human neutrophils infected with Afa/Dr diffusely adhering Escherichia coli strains. Infect Immun 2004; 72:5741-5749. PMID: 15385473; http://dx.doi.org/10.1128/IAI.72.10.5741-5749.2004
78. Guignot J, Chaplais C, Coconnier-Polter MH, Servin AL. The secreted autotransporter toxin, Sat, functions as a virulence factor in Afa/Dr diffusely adhering Escherichia coli by promoting lesions in tight junction of polarized epithelial cells. Cell Microbiol 2007; 9:204-221. PMID:16903846; http://dx.doi.org/10.1111/j.1462-5822.2006.00782.x
79. Maroncle NM, Sivick KE, Brady R, Stokes FE, Mobley HL. Protease activity, secretion, cell entry, cytotoxicity, and cellular targets of secreted autotransporter toxin of uropathogenic Escherichia coli. Infect Immun 2006; 74:6124-6134. PMID:16954394; http://dx.doi.org/10.1128/IAI.01086-06
80. Liévin-Le Moal V, Comenge Y, Ruby V, Amsellem R, Nicolas V, Servin AL. Secreted autotransporter toxin (Sat) triggers autophagy in epithelial cells that relies on cell detachment. Cell Microbiol 2011; 13:992-1013. PMID:21501364; http://dx.doi.org/10.1111/j.1462-5822.2011.01595.x
81. Martinez-Medina M, Mora A, Blanco M, López C, Alonso MP, Bonacorsi S, et al. Similarity and divergence among adherent-invasive Escherichia coli and extraintestinal pathogenic E. coli strains. J Clin Microbiol 2009; 47:3968-3979. PMID:19828750; http://dx.doi.org/10.1128/JCM.01484-09
82. Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, Allez M, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007; 117:1566-1574. PMID:17525800; http://dx.doi.org/10.1172/JCI30504
83. Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CH, Stanners CP, et al. Crohn's disease adherentinvasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 2009; 206:2179-2189. PMID: 19737864; http://dx.doi.org/10.1084/jem.20090741
84. Chassaing B, Rolhion N, de Vallée A, Salim SY, Prorok-Hamon M, Neut C, et al. Crohn disease-associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. J Clin Invest 2011; 121:966-975. PMID: 21339647; http://dx.doi.org/10.1172/JCI44632
85. Rolhion N, Barnich N, Claret L, Darfeuille-Michaud A. Strong decrease in invasive ability and outer membrane vesicle release in Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 with the yfgL gene deleted. J Bacteriol 2005; 187:2286-2296. PMID:15774871; http://dx.doi.org/10.1128/JB.187.7.2286-2296.2005
86. Rolhion N, Barnich N, Bringer MA, Glasser AL, Ranc J, Hébuterne X, et al. Abnormally expressed ER stress response chaperone Gp96 in CD favours adherentinvasive Escherichia coli invasion. Gut 2010; 59:1355-1362. PMID:20587550; http://dx.doi.org/10.1136/gut.2010.207456
87. Boudeau J, Glasser AL, Masseret E, Joly B, Darfeuille-Michaud A. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun 1999; 67:4499-4509. PMID:10456892
88. Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colombel JF, Darfeuille-Michaud A. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun 2001; 69:5529-5537. PMID:11500426; http://dx.doi.org/10.1128/IAI.69.9.5529-5537.2001
89. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci U S A 1995; 92:1664-168. PMID:7878036; http://dx.doi.org/10.1073/pnas.92.5.1664
90. Elliott SJ, Wainwright LA, McDaniel TK, Jarvis KG, Deng YK, Lai LC, et al. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol Microbiol 1998; 28:1-4. PMID:9593291; http://dx.doi.org/10.1046/j.1365-2958.1998.00783.x
91. Feng P, Lampel KA, Karch H, Whittam TS. Genotypic and phenotypic changes in the emergence of Escherichia coli O157:H7. J Infect Dis 1998; 177:1750-1753. PMID:9607864; http://dx.doi.org/10.1086/517438
92. Ogura Y, Ooka T, Iguchi A, Toh H, Asadulghani M, Oshima K, et al. Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc Natl Acad Sci U S A 2009; 106:17939-17944. PMID:19815525; http://dx.doi.org/10.1073/pnas.0903585106
93. Trabulsi LR, Keller R, Tardelli Gomes TA. Typical and atypical enteropathogenic Escherichia coli. Emerg Infect Dis 2002; 8:508-513. PMID:11996687
94. Girón JA, Ho AS, Schoolnik GK. An inducible bundle-forming pilus of enteropathogenic Escherichia coli. Science 1991; 254:710-713. PMID:1683004; http://dx.doi.org/10.1126/science.1683004
95. Scaletsky IC, Silva ML, Trabulsi LR. Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells. Infect Immun 1984; 45:534-536. PMID:6146569
96. Fitzhenry R, Dahan S, Torres AG, Chong Y, Heuschkel R, Murch SH, et al. Long polar fimbriae and tissue tropism in Escherichia coli O157:H7. Microbes Infect 2006; 8:1741-1749. PMID:16815722; http://dx.doi.org/10.1016/j.micinf.2006.02.012
97. Nicholls L, Grant TH, Robins-Browne RM. Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells. Mol Microbiol 2000; 35:275-288. PMID:10652089; http://dx.doi.org/10.1046/j.1365-2958.2000.01690.x
98. Torres AG, Li Y, Tutt CB, Xin L, Eaves-Pyles T, Soong L. Outer membrane protein A of Escherichia coli O157:H7 stimulates dendritic cell activation. Infect Immun 2006; 74:2676-2685. PMID:16622204; http://dx.doi.org/10.1128/IAI.74.5.2676-2685.2006
99. Batisson I, Guimond MP, Girard F, An H, Zhu C, Oswald E, et al. Characterization of the novel factor paa involved in the early steps of the adhesion mechanism of attaching and effacing Escherichia coli. Infect Immun 2003; 71:4516-4525. PMID:12874331; http://dx.doi.org/10.1128/IAI.71.8.4516-4525.2003
100. Paton AW, Srimanote P, Woodrow MC, Paton JC. Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacementnegative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect Immun 2001; 69:6999-7009. PMID:11598075; http://dx.doi.org/10.1128/IAI.69.11.6999-7009.2001
101. Lu Y, Iyoda S, Satou H, Satou H, Itoh K, Saitoh T, et al. A new immunoglobulin-binding protein, EibG, is responsible for the chain-like adhesion phenotype of locus of enterocyte effacement-negative, shiga toxinproducing Escherichia coli. Infect Immun 2006; 74:5747-5755. PMID:16988252; http://dx.doi.org/10.1128/IAI.00724-06
102. Wells TJ, Sherlock O, Rivas L, Mahajan A, Beatson SA, Torpdahl M, et al. EhaA is a novel autotransporter protein of enterohemorrhagic Escherichia coli O157: H7 that contributes to adhesion and biofilm formation. Environ Microbiol 2008; 10:589-604. PMID: 18237301; http://dx.doi.org/10.1111/j.1462-2920.2007.01479.x
103. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000; 342:1930-1936. PMID:10874060; http://dx.doi.org/10.1056/NEJM200006293422601
104. Johannes L, Römer W. Shiga toxins-from cell biology to biomedical applications. Nat Rev Microbiol 2010; 8:105-116. PMID:20023663
105. Römer W, Berland L, Chambon V, Gaus K, Windschiegl B, Tenza D, et al. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 2007; 450:670-675. PMID:18046403; http://dx.doi.org/10.1038/nature05996
106. Mallard F, Antony C, Tenza D, Salamero J, Goud B, Johannes L. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J Cell Biol 1998; 143:973-990. PMID:9817755; http://dx.doi.org/10.1083/jcb.143.4.973
107. Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 1988; 171:45-50. PMID: 3276522; http://dx.doi.org/10.1111/j.1432-1033.1988.tb13756.x
108. Falguières T, Mallard F, Baron C, Hanau D, Lingwood C, Goud B, et al. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell 2001; 12:2453-2468. PMID:11514628
109. Lee SY, Lee MS, Cherla RP, Tesh VL. Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells. Cell Microbiol 2008; 10:770-780. PMID:18005243; http://dx.doi.org/10.1111/j.1462-5822.2007.01083.x
110. Fujii J, Wood K, Matsuda F, Carneiro-Filho BA, Schlegel KH, Yutsudo T, et al. Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein. Infect Immun 2008; 76:3679-3689. PMID:18541659; http://dx.doi.org/10.1128/IAI.01581-07
111. Vidal JE, Navarro-García F. EspC translocation into epithelial cells by enteropathogenic Escherichia coli requires a concerted participation of type V and III secretion systems. Cell Microbiol 2008; 10:1975-1986. PMID:18547338; http://dx.doi.org/10.1111/j.1462-5822.2008.01181.x
112. Khan AB, Naim A, Orth D, Grif K, Mohsin M, Prager R, et al. Serine protease espP subtype alpha, but not beta or gamma, of Shiga toxin-producing Escherichia coli is associated with highly pathogenic serogroups. Int J Med Microbiol 2009; 299:247-254. PMID: 19036636; http://dx.doi.org/10.1016/j.ijmm.2008.08.006
113. Orth D, Ehrlenbach S, Brockmeyer J, Khan AB, Huber G, Karch H, et al. EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5. Infect Immun 2010; 78:4294-4301. PMID:20643852; http://dx.doi.org/10.1128/IAI.00488-10
114. Ghosh P. Process of protein transport by the type III secretion system. Microbiol Mol Biol Rev 2004; 68:771-795. PMID:15590783; http://dx.doi.org/10.1128/MMBR.68.4.771-795.2004
115. Knutton S, Rosenshine I, Pallen MJ, Nisan I, Neves BC, Bain C, et al. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J 1998; 17:2166-2176. PMID:9545230; http://dx.doi.org/10.1093/emboj/17.8.2166
116. Wachter C, Beinke C, Mattes M, Schmidt MA. Insertion of EspD into epithelial target cell membranes by infecting enteropathogenic Escherichia coli. Mol Microbiol 1999; 31:1695-1707. PMID:10209743; http://dx.doi.org/10.1046/j.1365-2958.1999.01303.x
117. Wolff C, Nisan I, Hanski E, Frankel G, Rosenshine I. Protein translocation into host epithelial cells by infecting enteropathogenic Escherichia coli. Mol Microbiol 1998; 28:143-155. PMID:9593303; http://dx.doi.org/10.1046/j.1365-2958.1998.00782.x
118. Tobe T, Beatson SA, Taniguchi H, Abe H, Bailey CM, Fivian A, et al. An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci U S A 2006; 103:14941-14946. PMID: 16990433; http://dx.doi.org/10.1073/pnas.0604891103
119. Iguchi A, Thomson NR, Ogura Y, Saunders D, Ooka T, Henderson IR, et al. Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J Bacteriol 2009; 191:347-354. PMID:18952797; http://dx.doi.org/10.1128/JB.01238-08
120. Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol 2011; 80:1420-1438. PMID:21488979; http://dx.doi.org/10.1111/j.1365-2958.2011.07661.x
121. Frankel G, Phillips AD, Rosenshine I, Dougan G, Kaper JB, Knutton S. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol Microbiol 1998; 30:911-921. PMID: 9988469; http://dx.doi.org/10.1046/j.1365-2958.1998.01144.x
122. Jerse AE, Yu J, Tall BD, Kaper JB. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 1990; 87:7839-7843. PMID:2172966; http://dx.doi.org/10.1073/pnas.87.20.7839
123. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB. A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci U S A 1995; 92:1664-1668. PMID:7878036; http://dx.doi.org/10.1073/pnas.92.5.1664
124. Touzé T, Hayward RD, Eswaran J, Leong JM, Koronakis V. Self-association of EPEC intimin mediated by the beta-barrel-containing anchor domain: a role in clustering of the Tir receptor. Mol Microbiol 2004; 51:73-87. PMID:14651612; http://dx.doi.org/10.1046/j.1365-2958.2003.03830.x
125. Adu-Bobie J, Frankel G, Bain C, Goncalves AG, Trabulsi LR, Douce G, et al. Detection of intimins alpha, beta, gamma, and delta, four intimin derivatives expressed by attaching and effacing microbial pathogens. J Clin Microbiol 1998; 36:662-668. PMID: 9508292
126. Lacher DW, Steinsland H, Whittam TS. Allelic subtyping of the intimin locus (eae) of pathogenic Escherichia coli by fluorescent RFLP. FEMS Microbiol Lett 2006; 261:80-87. PMID:16842363; http://dx.doi.org/10.1111/j.1574-6968.2006.00328.x
127. Frankel G, Lider O, Hershkoviz R, Mould AP, Kachalsky SG, Candy DC, et al. The cell-binding domain of intimin from enteropathogenic Escherichia coli binds to beta1 integrins. J Biol Chem 1996; 271:20359-20364. PMID:8702771; http://dx.doi.org/10.1074/jbc.271.34.20359
128. Isberg RR, Leong JM. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 1990; 60:861-871. PMID:2311122; http://dx.doi.org/10.1016/0092-8674(90)90099-Z
129. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 1997; 91:511-520. PMID: 9390560; http://dx.doi.org/10.1016/S0092-8674(00)80437-7
130. Robinson CM, Sinclair JF, Smith MJ, O'Brien AD. Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc Natl Acad Sci U S A 2006; 103:9667-9672. PMID:16766659; http://dx.doi.org/10.1073/pnas.0602359103
131. Gruenheid S, DeVinney R, Bladt F, Goosney D, Gelkop S, Gish GD, et al. Enteropathogenic E. coli Tir binds Nck to initiate actin pedestal formation in host cells. Nat Cell Biol 2001; 3:856-859. PMID:11533668; http://dx.doi.org/10.1038/ncb0901-856
132. Phillips N, Hayward RD, Koronakis V. Phosphorylation of the enteropathogenic E. coli receptor by the Src-family kinase c-Fyn triggers actin pedestal formation. Nat Cell Biol 2004; 6:618-625. PMID:15220932; http://dx.doi.org/10.1038/ncb1148
133. Campellone KG, Giese A, Tipper DJ, Leong JM. A tyrosine-phosphorylated 12-amino-acid sequence of enteropathogenic Escherichia coli Tir binds the host adaptor protein Nck and is required for Nck localization to actin pedestals. Mol Microbiol 2002; 43:1227-1241. PMID:11918809; http://dx.doi.org/10.1046/j.1365-2958.2002.02817.x
134. Garmendia J, Phillips AD, Carlier MF, Chong Y, Schüller S, Marches O, et al. TccP is an enterohaemorrhagic Escherichia coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell Microbiol 2004; 6:1167-1183. PMID:15527496; http://dx.doi.org/10.1111/j.1462-5822.2004.00459.x
135. Campellone KG, Robbins D, Leong JM. EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes Nck-independent actin assembly. Dev Cell 2004; 7:217-228. PMID: 15296718; http://dx.doi.org/10.1016/j.devcel.2004.07.004
136. Brady MJ, Campellone KG, Ghildiyal M, Leong JM. Enterohaemorrhagic and enteropathogenic Escherichia coli Tir proteins trigger a common Nck-independent actin assembly pathway. Cell Microbiol 2007; 9:2242-2253. PMID:17521329; http://dx.doi.org/10.1111/j.1462-5822.2007.00954.x
137. Vingadassalom D, Kazlauskas A, Skehan B, Cheng HC, Magoun L, Robbins D, et al. Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation. Proc Natl Acad Sci U S A 2009; 106:6754-6759. PMID:19366662; http://dx.doi.org/10.1073/pnas.0809131106
138. Campellone KG, Leong JM. Nck-independent actin assembly is mediated by two phosphorylated tyrosines within enteropathogenic Escherichia coli Tir. Mol Microbiol 2005; 56:416-432. PMID:15813734; http://dx.doi.org/10.1111/j.1365-2958.2005.04558.x
139. Cheng HC, Skehan BM, Campellone KG, Leong JM, Rosen MK. Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspF(U). Nature 2008; 454:1009-1013. PMID:18650809; http://dx.doi.org/10.1038/nature07160
140. Ogura Y, Ooka T, Whale A, Garmendia J, Beutin L, Tennant S, et al. TccP2 of O157:H7 and non-O157 enterohemorrhagic Escherichia coli (EHEC): challenging the dogma of EHEC-induced actin polymerization. Infect Immun 2007; 75:604-612. PMID: 17101643; http://dx.doi.org/10.1128/IAI.01491-06
141. Whale AD, Garmendia J, Gomes TA, Frankel G. A novel category of enteropathogenic Escherichia coli simultaneously utilizes the Nck and TccP pathways to induce actin remodelling. Cell Microbiol 2006; 8:999-1008. PMID:16681840; http://dx.doi.org/10.1111/j.1462-5822.2006.00682.x
142. Crepin VF, Girard F, Schüller S, Phillips AD, Mousnier A, Frankel G. Dissecting the role of the Tir:Nck and Tir:IRTKS/IRSp53 signalling pathways in vivo. Mol Microbiol 2010; 75:308-323. PMID: 19889090; http://dx.doi.org/10.1111/j.1365-2958.2009.06938.x
143. Schüller S, Chong Y, Lewin J, Kenny B, Frankel G, Phillips AD. Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models. Cell Microbiol 2007; 9:1352-1364. PMID: 17474908; http://dx.doi.org/10.1111/j.1462-5822.2006.00879.x
144. Ritchie JM, Brady MJ, Riley KN, Ho TD, Campellone KG, Herman IM, et al. EspFU, a type III-translocated effector of actin assembly, fosters epithelial association and late-stage intestinal colonization by E. coli O157:H7. Cell Microbiol 2008; 10:836-847. PMID:18067584; http://dx.doi.org/10.1111/j.1462-5822.2007.01087.x
145. Bulgin R, Raymond B, Garnett JA, Frankel G, Crepin VF, Berger CN, et al. Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors. Infect Immun 2010; 78:1417-1425. PMID:20123714; http://dx.doi.org/10.1128/IAI.01250-09
146. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998; 279:509-414. PMID:9438836; http://dx.doi.org/10.1126/science.279.5350.509
147. Huang Z, Sutton SE, Wallenfang AJ, Orchard RC, Wu X, Feng Y, et al. Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics. Nat Struct Mol Biol 2009; 16:853-860. PMID: 19620963; http://dx.doi.org/10.1038/nsmb.1647
148. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005; 21:247-269. PMID:16212495; http://dx.doi.org/10.1146/annurev.cellbio.21.020604.150721
149. Alto NM, Shao F, Lazar CS, Brost RL, Chua G, Mattoo S, et al. Identification of a bacterial type III effector family with G protein mimicry functions. Cell 2006; 124:133-145. PMID:16413487; http://dx.doi.org/10.1016/j.cell.2005.10.031
150. Kenny B, Ellis S, Leard AD, Warawa J, Mellor H, Jepson MA. Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules. Mol Microbiol 2002; 44:1095-1107. PMID:12046591; http://dx.doi.org/10.1046/j.1365-2958.2002.02952.x
151. Arbeloa A, Bulgin RR, MacKenzie G, Shaw RK, Pallen MJ, Crepin VF, et al. Subversion of actin dynamics by EspM effectors of attaching and effacing bacterial pathogens. Cell Microbiol 2008; 10:1429-1441. PMID: 18331467; http://dx.doi.org/10.1111/j.1462-5822.2008.01136.x
152. Bulgin R, Arbeloa A, Goulding D, Dougan G, Crepin VF, Raymond B, et al. The T3SS effector EspT defines a new category of invasive enteropathogenic E. coli (EPEC) which form intracellular actin pedestals. PLoS Pathog 2009; 5:e1000683. PMID:20011125; http://dx.doi.org/10.1371/journal.ppat.1000683
153. Tu X, Nisan I, Yona C, Hanski E, Rosenshine I. EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol Microbiol 2003; 47:595-606. PMID: 12535063; http://dx.doi.org/10.1046/j.1365-2958.2003.03329.x
154. Dong N, Liu L, Shao F. A bacterial effector targets host DH-PH domain RhoGEFs and antagonizes macrophage phagocytosis. EMBO J 2010; 29:1363-1376. PMID:20300064; http://dx.doi.org/10.1038/emboj.2010.33
155. Arbeloa A, Oates CV, Marchès O, Hartland EL, Frankel G. Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells. Infect Immun 2011; 79:1067-1076. PMID: 21189318; http://dx.doi.org/10.1128/IAI.01003-10
156. Dean P, Maresca M, Schüller S, Phillips AD, Kenny B. Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins. Proc Natl Acad Sci U S A 2006; 103:1876-1881. PMID:16446436; http://dx.doi.org/10.1073/pnas.0509451103
157. Iizumi Y, Sagara H, Kabe Y, Azuma M, Kume K, Ogawa M, et al. The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function. Cell Host Microbe 2007; 2:383-392. PMID:18078690; http://dx.doi.org/10.1016/j.chom.2007.09.012
158. Gill RK, Borthakur A, Hodges K, Turner JR, Clayburgh DR, Saksena S, et al. Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli. J Clin Invest 2007; 117:428-437. PMID:17256057; http://dx.doi.org/10.1172/JCI29625
159. Clements A, Smollett K, Lee SF, Hartland EL, Lowe M, Frankel G. EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function. Cell Microbiol 2011; 13:1429-1439. PMID: 21740499; http://dx.doi.org/10.1111/j.1462-5822.2011.01631.x
160. Selyunin AS, Sutton SE, Weigele BA, Reddick LE, Orchard RC, Bresson SM, et al. The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold. Nature 2011; 469:107-111. PMID: 21170023; http://dx.doi.org/10.1038/nature09593
161. Tomson FL, Viswanathan VK, Kanack KJ, Kanteti RP, Straub KV, Menet M, et al. Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier. Mol Microbiol 2005; 56:447-464. PMID:15813736; http://dx.doi.org/10.1111/j.1365-2958.2005.04571.x
162. Matsuzawa T, Kuwae A, Abe A. Enteropathogenic Escherichia coli type III effectors EspG and EspG2 alter epithelial paracellular permeability. Infect Immun 2005; 73:6283-6289. PMID:16177299; http://dx.doi.org/10.1128/IAI.73.10.6283-6289.2005
163. Hodges K, Alto NM, Ramaswamy K, Dudeja PK, Hecht G. The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity. Cell Microbiol 2008; 10:1735-1745. PMID:18433466; http://dx.doi.org/10.1111/j.1462-5822.2008.01163.x
164. Guttman JA, Samji FN, Li Y, Deng W, Lin A, Finlay BB. Aquaporins contribute to diarrhoea caused by attaching and effacing bacterial pathogens. Cell Microbiol 2007; 9:131-141. PMID:16889624; http://dx.doi.org/10.1111/j.1462-5822.2006.00773.x
165. Dean P, Kenny B. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol Microbiol 2004; 54:665-675. PMID:15491358; http://dx.doi.org/10.1111/j.1365-2958.2004.04308.x
166. Thanabalasuriar A, Koutsouris A, Weflen A, Mimee M, Hecht G, Gruenheid S. The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. Cell Microbiol 2010; 12:31-41. PMID:19712078; http://dx.doi.org/10.1111/j.1462-5822.2009.01376.x
167. Kim J, Thanabalasuriar A, Chaworth-Musters T, Fromme JC, Frey EA, Lario PI, et al. The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. Cell Host Microbe 2007; 2:160-171. PMID:18005731; http://dx.doi.org/10.1016/j.chom.2007.07.010
168. Lee SF, Kelly M, McAlister A, Luck SN, Garcia EL, Hall RA, et al. A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium. Cell Microbiol 2008; 10:499-513. PMID:17979986
169. Schüller S, Lucas M, Kaper JB, Girón JA, Phillips AD. The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection. Cell Microbiol 2009; 11:521-530. PMID:19134113; http://dx.doi.org/10.1111/j.1462-5822.2008.01275.x
170. Ruchaud-Sparagano MH, Maresca M, Kenny B. Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell Microbiol 2007; 9:1909-1921. PMID:17388785; http://dx.doi.org/10.1111/j.1462-5822.2007.00923.x
171. Nadler C, Baruch K, Kobi S, Mills E, Haviv G, Farago M, et al. The type III secretion effector NleE inhibits NF-kappaB activation. PLoS Pathog 2010; 6: e1000743. PMID:20126447; http://dx.doi.org/10.1371/journal.ppat.1000743
172. Newton HJ, Pearson JS, Badea L, Kelly M, Lucas M, Holloway G, et al. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog 2010; 6:e1000898. PMID: 20485572; http://dx.doi.org/10.1371/journal.ppat.1000898
173. Pearson JS, Riedmaier P, Marchès O, Frankel G, Hartland EL. A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-kB for degradation. Mol Microbiol 2011; 80:219-230. PMID: 21306441; http://dx.doi.org/10.1111/j.1365-2958.2011.07568.x
174. Baruch K, Gur-Arie L, Nadler C, Koby S, Yerushalmi G, Ben-Neriah Y, et al. Metalloprotease type III effectors that specifically cleave JNK and NF-kB. EMBO J 2011; 30:221-231. PMID:21113130; http://dx.doi.org/10.1038/emboj.2010.297
175. Hemrajani C, Marches O, Wiles S, Girard F, Dennis A, Dziva F, et al. Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect Immun 2008; 76:4804-4813. PMID:18725419; http://dx.doi.org/10.1128/IAI.00742-08
176. Royan SV, Jones RM, Koutsouris A, Roxas JL, Falzari K, Weflen AW, et al. Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-kB activation. Mol Microbiol 2010; 78:1232-1245. PMID:21091507; http://dx.doi.org/10.1111/j.1365-2958.2010.07400.x
177. Gao X, Wan F, Mateo K, Callegari E, Wang D, Deng W, et al. Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog 2009; 5:e1000708. PMID:20041225; http://dx.doi.org/10.1371/journal.ppat.1000708
178. Wan F, Weaver A, Gao X, Bern M, Hardwidge PR, Lenardo MJ. IKKβ phosphorylation regulates RPS3 nuclear translocation and NF-kB function during infection with Escherichia coli strain O157:H7. Nat Immunol 2011; 12:335-343. PMID:21399639; http://dx.doi.org/10.1038/ni.2007
179. Raymond B, Crepin VF, Collins JW, Frankel G. The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-kB-dependent manner. Cell Microbiol 2011; 13:1881-1893. PMID: 21848814; http://dx.doi.org/10.1111/j.1462-5822.2011.01666.x
180. Crane JK, Majumdar S, Pickhardt DF, 3rd. Host cell death due to enteropathogenic Escherichia coli has features of apoptosis. Infect Immun 1999; 67:2575-2584. PMID:10225923
181. Barnett Foster D, Abul-Milh M, Huesca M, Lingwood CA. Enterohemorrhagic Escherichia coli induces apoptosis which augments bacterial binding and phosphatidylethanolamine exposure on the plasma membrane outer leaflet. Infect Immun 2000; 68:3108-3115. PMID:10816451; http://dx.doi.org/10.1128/IAI.68.6.3108-3115.2000
182. Nougayrède JP, Donnenberg MS. Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway. Cell Microbiol 2004; 6:1097-1111. PMID:15469437; http://dx.doi.org/10.1111/j.1462-5822.2004.00421.x
183. Samba-Louaka A, Nougayrède JP, Watrin C, Oswald E, Taieb F. The enteropathogenic Escherichia coli effector Cif induces delayed apoptosis in epithelial cells. Infect Immun 2009; 77:5471-5477. PMID: 19786559; http://dx.doi.org/10.1128/IAI.00860-09
184. Crane JK, McNamara BP, Donnenberg MS. Role of EspF in host cell death induced by enteropathogenic Escherichia coli. Cell Microbiol 2001; 3:197-211. PMID:11298644; http://dx.doi.org/10.1046/j.1462-5822.2001.00103.x
185. Hemrajani C, Berger CN, Robinson KS, Marchès O, Mousnier A, Frankel G. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc Natl Acad Sci U S A 2010; 107:3129-3134. PMID:20133763; http://dx.doi.org/10.1073/pnas.0911609106
186. Baruch K, Gur-Arie L, Nadler C, Koby S, Yerushalmi G, Ben-Neriah Y, et al. Metalloprotease type III effectors that specifically cleave JNK and NF-kB. EMBO J 2011; 30:221-231. PMID:21113130; http://dx.doi.org/10.1038/emboj.2010.297
187. Shames SR, Deng W, Guttman JA, de Hoog CL, Li Y, Hardwidge PR, et al. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling. Cell Microbiol 2010; 12:1322-1339. PMID:20374249; http://dx.doi.org/10.1111/j.1462-5822.2010.01470.x
188. Kim M, Ogawa M, Fujita Y, Yoshikawa Y, Nagai T, Koyama T, et al. Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. Nature 2009; 459:578-582. PMID:19489119; http://dx.doi.org/10.1038/nature07952
189. Crane JK, Oh JS. Activation of host cell protein kinase C by enteropathogenic Escherichia coli. Infect Immun 1997; 65:3277-3285. PMID:9234787
190. Rosenshine I, Donnenberg MS, Kaper JB, Finlay BB. Signal transduction between enteropathogenic Escherichia coli (EPEC) and epithelial cells: EPEC induces tyrosine phosphorylation of host cell proteins to initiate cytoskeletal rearrangement and bacterial uptake. EMBO J 1992; 11:3551-3560. PMID:1396556
191. Sason H, Milgrom M, Weiss AM, Melamed-Book N, Balla T, Grinstein S, et al. Enteropathogenic Escherichia coli subverts phosphatidylinositol 4,5- bisphosphate and phosphatidylinositol 3,4,5-trisphosphate upon epithelial cell infection. Mol Biol Cell 2009; 20:544-555. PMID:18987340; http://dx.doi.org/10.1091/mbc.E08-05-0516
192. Quitard S, Dean P, Maresca M, Kenny B. The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting. Cell Microbiol 2006; 8:972-981. PMID:16681838; http://dx.doi.org/10.1111/j.1462-5822.2005.00680.x
193. Iizumi Y, Sagara H, Kabe Y, Azuma M, Kume K, Ogawa M, et al. The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function. Cell Host Microbe 2007; 2:383-392. PMID:18078690; http://dx.doi.org/10.1016/j.chom.2007.09.012
194. Marchès O, Covarelli V, Dahan S, Cougoule C, Bhatta P, Frankel G, et al. EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsonophagocytosis. Cell Microbiol 2008; 10:1104-1115. PMID:18201246; http://dx.doi.org/10.1111/j.1462-5822.2007.01112.x